Furthermore, PEITC treatment resulted in the restoration of normal p53 checkpoint control pathway in mutant p53-expressing cancer cells, which normally functions to inhibit cell transformation, and its inactivation has been correlated with tumor cell growth and survival [134]. This evidence concerns the gene TP53 and neoplasm.